Skip to main content

Conditions

Hyperammonemia

The presence of too much ammonia in the blood.

11 passages
3 authors
2013–2024
Most-cited: Georgi Dinkov

Hyperammonemia is a state of elevated ammonia in the blood, which Ray Peat and Georgi Dinkov describe as a highly toxic condition resulting primarily from the inefficient metabolism of protein when carbon dioxide production is insufficient to detoxify it into urea. Dinkov has written that ammonia is a true waste product generated when amino acids are deaminated for fuel rather than used for tissue synthesis, a process that becomes pathological when metabolic rate is low. Peat argued that the smell of ammonia on a person's breath or skin is usually a sign of insufficient thyroid function, though he noted it could also stem from kidney problems or bacterial action on sweat.

The primary driver of hyperammonemia is the catabolic use of protein as an energy source, which occurs when carbohydrate intake is inadequate or stress hormones are elevated. Dinkov explains that consuming more than roughly 30 grams of protein in a single meal without sufficient carbohydrates forces the body to deaminate the excess amino acids, cleaving the amino group and releasing ammonia as a byproduct. This process is amplified by cortisol, the master catabolic hormone, which shreds muscle tissue and floods the bloodstream with amino acids, upregulating gluconeogenesis and overwhelming the liver's capacity to convert ammonia into urea. Roddy and his guest Kyle Mamounis have discussed how even subclinical reliance on gluconeogenesis from a low-carbohydrate diet chronically elevates ammonia production, and that the urea cycle is saturable, meaning the body cannot simply upregulate detoxification to match a high protein intake.

The toxicity of ammonia is systemic, but it is most damaging to the brain, where it can cause conditions ranging from insomnia, fatigue, and mania to hyperammonemic encephalopathy and coma. Dinkov notes that this is the typical cause of death in advanced liver failure, as the damaged liver can no longer process ammonia, leading to a hyperammonemic coma of hepatic origin. Peat's framework emphasizes that the detoxification of ammonia into benign urea is directly dependent on carbon dioxide, which combines with ammonia in a reaction that requires a robust oxidative metabolism. Therefore, any factor that suppresses metabolic rate—such as hypothyroidism, estrogen excess, or a deficiency of B vitamins like riboflavin—predisposes an individual to ammonia accumulation.

Dinkov has extended this view by identifying specific interventions that can chelate or excrete ammonia. He points to Ceylon cinnamon as a practical remedy, explaining that it metabolizes into benzoic acid and conjugates with ammonia to form hippuric acid, which is then excreted in urine, mirroring the mechanism of the pharmaceutical drug Ucephal. He also notes that the hyperammonemia observed in some viral infections may be an adaptive, antiviral response, and that substances like adamantane can functionally oppose the estrogen-driven excitotoxic systems that ammonia toxicity exacerbates. The bioenergetic perspective thus frames hyperammonemia not as an isolated pathology but as a direct consequence of a low metabolic rate where the protective, anabolic use of protein has been supplanted by a toxic, catabolic one.

People also ask

Related concepts

Analytics and on-error session replay stay off until you accept. See our Privacy Policy.